Dr Rebecca Goldstein has been awarded a Monash Partners MP STAR Clinician Fellowship to research high-risk pregnancy, diabetes and implementation.
In response to a lack of clinical academic pathways across all health disciplines in Australia, Monash Partners has launched a program to support promising clinical academics embedded in healthcare, and train the next generation of clinician researchers.
The Monash Partners Strategic Translation and Research (MP STAR) Clinician Fellow Program responds to an identified need to strengthen and build the multi-disciplinary clinical academic workforce. It is designed to foster and embed research into practice and equip emerging and mid-career clinical academics with important skills, knowledge and experience that supports career progression toward future leadership roles.
The program provides fellowship funding, combined with protected research time, networking, mentoring and training to provide a pathway to combine research with clinical care.
MCHRI researcher, Dr Rebecca Goldstein is a 2023 MP STAR recipient. She is also a consultant Endocrinologist at Monash Health.
“This fellowship gives me the opportunity to expand my research in the field of high-risk pregnancy, including women with diabetes and women at risk of cardiometabolic disease. I will identify women who will benefit most from risk reduction, explore metformin use in pregnancy, and lead implementation research on interventions for high risk women. I will combine this with my clinical work as an Endocrinologist in the Diabetes Service, taking a leadership role to embed research into healthcare for impact,” said Dr Goldstein.
Read more about the 2023 MP STAR recipients and the MP STAR Program on the Monash Partners website.